stopping glp 1 after weight loss Learn what happens when you stop taking a GLP-1 weight-loss drug and how to sustain results. #HarvardHealth In recent years, GLP-1 medications

Combination therapy with SGLT2 inhibitors + GLP-1 RAs may reduce cardiorenal risk and CV & all-cause mortality in T2D vs SGLT22 inhibitor and GLP-1 RA monotherapy

Background Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as breakthrough weight loss agents

Learn how GLP-1 medications may affect vision, from blurry sight to rare risks, plus potential eye health benefits and when to see an eye doctor.

Here, we highlight the mechanisms linking T2DM and PD, as well as the links between insulin resistance (IR) and PD patients risk of developing cognitive deficits

This global initiative reframed obesity as a chronic, systemic disease rather than a mere risk factor

Understanding these temporary side effects and how to minimize them helps patients stay on track with their weight loss goals